PH PRECISION MED
PH Precision Med is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension.
More informations about "PH Precision Med"
PH Precision Med Company Profile 2024: Valuation, Investors
Nov 25, 2019 PH Precision Med General Information Description. Operator of a clinical-stage biotech company based in Skokie, Illinois. The company is engaged in the clinical …See details»
Tenax Therapeutics acquires PH Precision Med - Crunchbase
PH Precision Med PHPM is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension. Acquiring Organization: Tenax …See details»
PH Precision Med - Products, Competitors, Financials, Employees ...
Jan 20, 2021 PH Precision Med (PHPM), a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension (PAH). On …See details»
Tenax Therapeutics, Inc. Announces Transformative Acquisition of …
Jan 19, 2021 Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical care market, …See details»
PH Precision Med - Drug pipelines, Patents, Clinical trials - Synapse
Explore PH Precision Med with its drug pipeline, therapeutic area, technology platform, . Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for …See details»
PH Precision Med - Crunchbase
PHPM is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension.See details»
Tenax Therapeutics, Inc. acquired PH Precision Med Inc. for $21.6 ...
Jan 18, 2021 Tenax Therapeutics, Inc. acquired PH Precision Med Inc. for $21.6 million on January 15, 2021. As consideration stockholders of PH Precision Med will receive 1.89 million …See details»
Tenax Buys PH Precision Med, Plans Trial for Oral Imatinib
Jan 20, 2021 We will now focus advancing therapeutic candidates for … pulmonary hypertension with a precision medicine approach, to allow us to achieve the optimal treatment …See details»
Zacks Small Cap Research - TENX: Tenax Picks Up PH Precision Med
Jan 21, 2021 By John Vandermosten, CFA. NASDAQ:TENX. Tenax Acquires PH Precision Med . Tenax Therapeutics, Inc. (NASDAQ:TENX) announced yesterday the acquisition of privately …See details»
Tenax Therapeutics, Inc. : Announces Transformative Acquisition of …
Jan 19, 2021 Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical care market, …See details»
Tenax Therapeutics Schedules Conference Call to Discuss Its ...
Jan 20, 2021 Tenax Therapeutics, Inc. (Nasdaq: TENX) to host conf. call & live audio webcast on Jan 21, 2021, at 4:30 pm to discuss acquisition of PH Precision MedSee details»
Tenax Therapeutics, Inc. Announces Transformative Acquisition of …
Jan 19, 2021 Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med Published. Jan 19, 2021 7:45AM EST.See details»
EPH208 Adoption of Precision Health (PH) and Precision Medicine …
PM is often associated with precision therapeutics, but recently, the use of PM and precision approaches, such as genetic-testing, are increasingly becoming more holistic, covering other …See details»
Precision Medicine | FDA - U.S. Food and Drug Administration
Precision medicine, sometimes known as "personalized medicine" is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people's …See details»
PH Precision Med - Updates, News, Events, Signals & Triggers
Organization. PH Precision Med . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Recent News & Activity. Edit Recent News & Activity Section ...See details»
Precision approach to population health can benefit patients and …
Jun 26, 2023 The European Federation of Pharmaceutical Industries and Associations (EFPIA), in collaboration with the EFPIA Oncology Platform (EOP), commissioned a report by Charles …See details»
Up close and personal with personalized precision medicine
Mar 16, 2016 LOUISVILLE, Ky. – Roland Valdes Jr., Ph.D., will explain how personalized precision medicine uses an individual patient’s genetic material (DNA) to improve drug …See details»
Precision medicine for brain tumors to be discussed at UofL
Jun 27, 2016 Aldape was part of an international team of medical researchers contributing to the 2016 World Health Organization Classification of Tumors of the Central Nervous System …See details»
Tenax Therapeutics, Inc. Announces Transformative Acquisition of …
Jan 19, 2021 MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and …See details»